A detailed history of Schechter Investment Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 116,784 shares of TAK stock, worth $1.53 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
116,784
Previous 115,290 1.3%
Holding current value
$1.53 Million
Previous $1.49 Million 11.27%
% of portfolio
0.17%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.0 - $15.08 $19,422 - $22,529
1,494 Added 1.3%
116,784 $1.66 Million
Q2 2024

Aug 12, 2024

SELL
$12.6 - $13.67 $151,363 - $164,217
-12,013 Reduced 9.44%
115,290 $1.49 Million
Q1 2024

May 06, 2024

SELL
$13.89 - $15.04 $23,515 - $25,462
-1,693 Reduced 1.31%
127,303 $1.77 Million
Q4 2023

Jan 17, 2024

SELL
$13.36 - $15.43 $72,037 - $83,198
-5,392 Reduced 4.01%
128,996 $1.84 Million
Q3 2023

Nov 06, 2023

SELL
$15.03 - $16.32 $63,126 - $68,544
-4,200 Reduced 3.03%
134,388 $2.08 Million
Q2 2023

Jul 26, 2023

SELL
$15.57 - $17.11 $23,292 - $25,596
-1,496 Reduced 1.07%
138,588 $2.18 Million
Q1 2023

Apr 28, 2023

SELL
$15.28 - $16.48 $12,926 - $13,942
-846 Reduced 0.6%
140,084 $2.31 Million
Q4 2022

Feb 13, 2023

BUY
$12.42 - $15.62 $675,014 - $848,931
54,349 Added 62.77%
140,930 $2.2 Million
Q3 2022

Nov 04, 2022

SELL
$12.8 - $28.65 $689,446 - $1.54 Million
-53,863 Reduced 38.35%
86,581 $1.12 Million
Q2 2022

Nov 03, 2022

BUY
$13.12 - $15.03 $1.84 Million - $2.11 Million
140,444 New
140,444 $1.97 Million
Q1 2022

Nov 18, 2022

BUY
$13.54 - $15.35 $827,442 - $938,053
61,111 Added 70.58%
147,692 $2.12 Million
Q4 2021

Dec 27, 2022

SELL
$13.17 - $16.4 $510,060 - $635,155
-38,729 Reduced 44.73%
47,852 $652,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.